Spero Therapeutics’ oral antibiotic tebipenem shows Phase 3 success and supports GSK’s NDA resubmission. Click here to read ...

KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced the acceptance of three abstracts for presentation at the 2026 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting ...

For many years, the idea that “sleeping on it” would provide an individual with some time in which their subconscious mind would work through a problem or problems has generally been accepted as ...

Amsterdam, February 10, 2026Full year and Q4 highlightsComparable order intake growth 6% in 2025; up 7% in Q4Group sales of EUR 17.8 billion in ...

Good day, everyone, and welcome to Pfizer's Fourth Quarter 2025 Earnings Conference Call. Today's call is being recorded. At ...

Six new classes are in the Spring 2026 schedule at the Institute for Learning in Retirement at Marietta College. Classes are ...

Generally overlooked in Art History 101 was the inverse: how European materials and images were repurposed by Indigenous ...

Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the Company generated revenue of $878 million for the fourth quarter of 2025 and ...

Lithia & Driveway (NYSE: LAD), largest global automotive retailer, today reported financial results for the fourth quarter and full year 2025.

The Johnson & Wales approach to education has always been richly experiential. Now, that real-world, hands-on focus is being fully integrated into every course, including those in the Core Curriculum.

DelveInsight is a leading provider of strategic conference coverage solutions, specializing in tracking, analyzing, and summarizing insights from global healthcare and pharmaceutical events across ...

She is a certified public accountant in New York and a member of the AICPA Tim Berendt Director of Discovery & Insights, ...